Factor Xa inhibitors

Details for Australian Patent Application No. 2005257999 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Scarborough, Robert M.; Probst, Gary D.; Zhu, Bing-Yan; Jia, Zhaozhong J.; Zhang, Yanchen; Bauer, Shawn M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005257999

PCT Pub. Number WO2006/002099

Priority 60/580,899 18.06.04 US

Filing date 20 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 8 December 2011

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2006/002099 Priority application(s): WO2006/002099

8 December 2011 Application Accepted

  Published as AU-B-2005257999

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258000-Diagnostic and screening methods and kits associated with proteolytic activity

2005257998-Sheet handling apparatus